AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

22 recruiting trials

for Invasive Breast Cancer Early Stages

Prospective Validation of Ataraxis AI Test for Predicting Treatment Response in Neoadjuvant Breast Cancer NCT07327970n/a1 site๐Ÿ“ Incheon Young-Joon Kang ยท Tests: multi-modal foundation AI test BRE-04: Window of Opportunity Trial of Preoperative Low Dose Azacitidine in High-Risk Early Stage Breast Cancer NCT04891068Phase 21 site๐Ÿ“ Chicago University of Illinois at Chicago ยท Tests: Azacitidine Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer NCT04553770Phase 29 sites๐Ÿ“ Fullerton๐Ÿ“ Los Alamitos๐Ÿ“ Los Angeles Jonsson Comprehensive Cancer Center ยท Tests: Anastrozole, Therapeutic Conventional Surgery, Trastuzumab Deruxtecan Radiation After No Axillary Nodal Sampling NCT07723209NA1 site๐Ÿ“ New York NYU Langone Health ยท Tests: Partial Breast Irradiation (PBI) Addition of Cisplatin to Adjuvant Chemotherapy for Early Stage Breast Cancer in High-Risk Women NCT03201861Phase 31 site๐Ÿ“ Shanghai RenJi Hospital ยท Tests: Paclitaxel, Cisplatin, EC to docetaxel or paclitaxel Long-Term Follow-up Study of Early Stage Breast Cancer Patients Included in GEICAM Studies NCT03390894n/a73 sites๐Ÿ“ Pamplona๐Ÿ“ Avilรฉs๐Ÿ“ San Cristรณbal de La Laguna Spanish Breast Cancer Research Group The Application of "HUAXI Hole 1" in Reverse-sequence Endoscopic Nipple-sparing Mastectomy With Direct-to-implant Breast Reconstruction NCT06995118NA20 sites๐Ÿ“ Fuzhou๐Ÿ“ Guangzhou๐Ÿ“ Anyang Du Zhenggui ยท Tests: HUAXI hole 1 Personalized Prone Immobilization for Accelerated Partial Breast Radiotherapy NCT07711847NA1 site๐Ÿ“ New York HeroSupport SA ยท Tests: VENUS SHELLโ„ข immobilization device Radiotherapy and Long-term Outcomes in Early Breast Cancer With SLNB Omission NCT07803081n/a1 site๐Ÿ“ Seoul Samsung Medical Center ยท Tests: Adjuvant Breast Radiotherapy Tirzepatide for Weight Loss Intervention in Early-Stage Hormone Receptor Positive/HER2 Negative Breast Cancer NCT06518837Phase 27 sites๐Ÿ“ Elizabeth๐Ÿ“ Hamilton๐Ÿ“ Livingston Rutgers, The State University of New Jersey ยท Tests: Tirzepatide Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancer NCT05020860Phase 22 sites๐Ÿ“ Houston๐Ÿ“ Houston Baylor Breast Care Center ยท Tests: Paclitaxel, Carboplatin, Trastuzumab, Pertuzumab, Doxorubicin Pre-operative SABR With and Without Caloric Restriction for Early Stage Breast Cancer NCT04959474NA1 site๐Ÿ“ Philadelphia Thomas Jefferson University ยท Tests: Best Practice, Stereotactic Body Radiation Therapy, Resection, Sentinel Lymph Node Biopsy, Dietary Intervention CRYoablation for Small Tumors As Local Treatment - SIX Trial NCT06839001Phase 32 sites๐Ÿ“ Sรฃo Paulo๐Ÿ“ Sรฃo Paulo Hospital do Coracao ยท Tests: cryoablation, Breast Surgery (Lumpectomy or Mastectomy) Time Restricted Eating for the Improvement of Outcomes in Patients With Stage I-III Breast Cancer Receiving Chemotherapy Before Surgery NCT05327608NA5 sites๐Ÿ“ Cherry Hill๐Ÿ“ Sewell๐Ÿ“ Philadelphia Thomas Jefferson University ยท Tests: Short-Term Fasting, Chemotherapy, Biospecimen Collection, Questionnaire Administration Effect of Huaier Granule on Adjuvant Treatment for High-risk Early-stage Triple-negative Breast Cancer NCT04790305Phase 434 sites๐Ÿ“ Hefei๐Ÿ“ Hefei๐Ÿ“ Beijing Fudan University ยท Tests: Huaier Granule Evaluation of Circulating Tumor Cells (CTC) Relevance in Breast Cancer Follow-up Using the ScreenCell Device NCT06807502NA1 site๐Ÿ“ Neuilly-sur-Seine ScreenCell ยท Tests: The DM/DIV ScreenCell is the experimental product studied during this research Preoperative Partial Breast Irradiation in Early-Stage Breast Cancer NCT06677944Phase 21 site๐Ÿ“ Seoul Yonsei University ยท Tests: Preoperative PBI Endoscopy/Robotic Assisted Nipple Skin Sparing Mastectomy NCT06823414n/a1 site๐Ÿ“ A Coruรฑa Alejandra Garcรญa-Novoa ยท Tests: Video assisted mastectomy Evaluating and Monitoring Immune and Clinical Responses in Early-Stage Triple Negative Breast Cancer Undergoing Neoadjuvant Chemo-immunotherapy With Pembrolizumab NCT05877859n/a1 site๐Ÿ“ Atlanta Emory University 5 vs. 9-day Course of Whole Breast Radiotherapy With Boost for Early-stage Breast Cancer NCT06961955Phase 21 site๐Ÿ“ Salt Lake City University of Utah ยท Tests: Radiation Therapy NabPE With or Without Serplulimab for Early-stage HR+/HER2- Breast Cancer. NCT06781281n/a1 site๐Ÿ“ Zhengzhou Henan Cancer Hospital ยท Tests: Serplulimab, NabPE Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection NCT05334069n/a747 sites๐Ÿ“ Anchorage๐Ÿ“ Anchorage๐Ÿ“ Anchorage Alliance for Clinical Trials in Oncology ยท Tests: Questionnaire Administration, Biospecimen Collection
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy